Clinical Cytogenetics/Clinical Genetics A45 (0169) 13.1 (0170) 1.89
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Diagnostic Investigations in Individuals with Mental Retardation: a Systematic Literature Review of Their Usefulness
European Journal of Human Genetics (2005) 13, 6–25 & 2005 Nature Publishing Group All rights reserved 1018-4813/05 $30.00 www.nature.com/ejhg REVIEW Diagnostic investigations in individuals with mental retardation: a systematic literature review of their usefulness Clara DM van Karnebeek1,2, Maaike CE Jansweijer2, Arnold GE Leenders1, Martin Offringa1 and Raoul CM Hennekam*,1,2 1Department of Paediatrics/Emma Children’s Hospital, Academic Medical Center, Amsterdam, The Netherlands; 2Department of Clinical Genetics, Academic Medical Center, Amsterdam, The Netherlands There are no guidelines available for diagnostic studies in patients with mental retardation (MR) established in an evidence-based manner. Here we report such study, based on information from original studies on the results with respect to detected significant anomalies (yield) of six major diagnostic investigations, and evaluate whether the yield differs depending on setting, MR severity, and gender. Results for cytogenetic studies showed the mean yield of chromosome aberrations in classical cytogenetics to be 9.5% (variation: 5.4% in school populations to 13.3% in institute populations; 4.1% in borderline- mild MR to 13.3% in moderate-profound MR; more frequent structural anomalies in females). The median yield of subtelomeric studies was 4.4% (also showing female predominance). For fragile X screening, yields were 5.4% (cytogenetic studies) and 2.0% (molecular studies) (higher yield in moderate-profound MR; checklist use useful). In metabolic investigations, the mean yield of all studies was 1.0% (results depending on neonatal screening programmes; in individual populations higher yield for specific metabolic disorders). Studies on neurological examination all showed a high yield (mean 42.9%; irrespective of setting, degree of MR, and gender). -
Characterization of SPECC1L Function in Palatogenesis
Characterization of SPECC1L Function in Palatogenesis By © 2019 Everett Gordon Hall B.A. Biology, Westminster College, Missouri, 2013 Submitted to the graduate degree program in Anatomy and Cell Biology and the Graduate Faculty of the University of Kansas in partial fulfillment of the requirements for the degree of Doctor of Philosophy. ________________________________________ Chair: Dr. Irfan Saadi ________________________________________ Dr. András Czirók ________________________________________ Dr. Brenda Rongish ________________________________________ Dr. Paul Trainor ________________________________________ Dr. Pamela Tran ________________________________________ Dr. Jinxi Wang Date Defended: April 26, 2019 The dissertation committee for Everett Gordon Hall certifies that this is the approved version of the following dissertation: Characterization of SPECC1L Function in Palatogenesis ________________________________________ Chair: Dr. Irfan Saadi Date Approved: May 16, 2019 ii Abstract Orofacial clefts are among the most common congenital birth defects, occurring in as many as 1 in 800 births worldwide. Genetic and environmental factors contribute to the complex etiology of these anomalies. SPECC1L encodes a cytoskeletal protein with roles in adhesion, migration, and cytoskeletal organization. SPECC1L mutations have been identified in patients with atypical clefts, Opitz G/BBB syndrome, and Teebi hypertelorism syndrome. Our lab has previously shown that knockout of Specc1l in mice with gene trap alleles results in early embryonic lethality with defects in neural tube closure and neural crest cell delamination, as well as reduced PI3K-AKT signaling. However, the early lethality phenotype rendered these models incapable of recapitulating the human anomalies. To validate a role for SPECC1L in palatogenesis, we generated additional gene trap and truncation mutant Specc1l alleles. Specc1lgenetrap/truncation compound heterozygote embryos survive to the perinatal period, allowing analysis at later developmental stages. -
Chest Wall Hypoplasia - Principles and Treatment
Paediatric Respiratory Reviews 16 (2015) 30–34 Contents lists available at ScienceDirect Paediatric Respiratory Reviews Mini-symposium: Chest Wall Disease Chest Wall Hypoplasia - Principles and Treatment Oscar Henry Mayer * Associate Professor of Clinical Pediatrics, Perelman School of Medicine at The University of Pennsylvania, Division of Pulmonary Medicine, The Children’s Hospital of Philadelphia, 3501 Civic Center Boulevard, Philadelphia, PA 19104 EDUCATIONAL AIMS Understand the significance of chest wall and spine growth on lung growth and respiration. Understand how abnormal spine growth can cause chest wall hypoplasia and the treatment options available. Understand how abnormal lateral chest wall growth can impact lung development and the options for therapy. A R T I C L E I N F O S U M M A R Y Keywords: The chest is a dynamic structure. For normal movement it relies on a coordinated movement of the Chest wall hypoplasia multiple bones, joints and muscles of the respiratory system. While muscle weakness can have clear Jeune Syndrome impact on respiration by decreasing respiratory motion, so can conditions that cause chest wall Jarcho-Levin Syndrome hypoplasia and produce an immobile chest wall. These conditions, such as Jarcho-Levin and Jeune Spondylocostal dysostosis syndrome, present significantly different challenges than those faced with early onset scoliosis in which Spondylothoracic dysplasia chest wall mechanics and thoracic volume may be much closer to normal. Because of this difference more aggressive approaches to clinical and surgical management are necessary. ß 2014 Elsevier Ltd. All rights reserved. abnormal or asymmetric growth in even a small number these can INTRODUCTION cause non-syndromic early onset scoliosis (EOS) [1]. -
Orphanet Report Series Rare Diseases Collection
Marche des Maladies Rares – Alliance Maladies Rares Orphanet Report Series Rare Diseases collection DecemberOctober 2013 2009 List of rare diseases and synonyms Listed in alphabetical order www.orpha.net 20102206 Rare diseases listed in alphabetical order ORPHA ORPHA ORPHA Disease name Disease name Disease name Number Number Number 289157 1-alpha-hydroxylase deficiency 309127 3-hydroxyacyl-CoA dehydrogenase 228384 5q14.3 microdeletion syndrome deficiency 293948 1p21.3 microdeletion syndrome 314655 5q31.3 microdeletion syndrome 939 3-hydroxyisobutyric aciduria 1606 1p36 deletion syndrome 228415 5q35 microduplication syndrome 2616 3M syndrome 250989 1q21.1 microdeletion syndrome 96125 6p subtelomeric deletion syndrome 2616 3-M syndrome 250994 1q21.1 microduplication syndrome 251046 6p22 microdeletion syndrome 293843 3MC syndrome 250999 1q41q42 microdeletion syndrome 96125 6p25 microdeletion syndrome 6 3-methylcrotonylglycinuria 250999 1q41-q42 microdeletion syndrome 99135 6-phosphogluconate dehydrogenase 67046 3-methylglutaconic aciduria type 1 deficiency 238769 1q44 microdeletion syndrome 111 3-methylglutaconic aciduria type 2 13 6-pyruvoyl-tetrahydropterin synthase 976 2,8 dihydroxyadenine urolithiasis deficiency 67047 3-methylglutaconic aciduria type 3 869 2A syndrome 75857 6q terminal deletion 67048 3-methylglutaconic aciduria type 4 79154 2-aminoadipic 2-oxoadipic aciduria 171829 6q16 deletion syndrome 66634 3-methylglutaconic aciduria type 5 19 2-hydroxyglutaric acidemia 251056 6q25 microdeletion syndrome 352328 3-methylglutaconic -
Pentalogy of Cantrell Sally DE Mohmmed1, Nadia Elrayah2, Helmi Noor3, Badreldeen Ahmed4
CASE REPORT Pentalogy of Cantrell Sally DE Mohmmed1, Nadia Elrayah2, Helmi Noor3, Badreldeen Ahmed4 Keywords: Cantrell, Pentalogy of Cantrell, Pentalogy Donald School Journal of Ultrasound in Obstetrics and Gynecology (2019): 10.5005/jp-journals-10009-1591 This is a 24-year-old primigravida patient married to her first cousin. 1–3 The patient was referred from a rural hospital to the Ian Donald University of Medical Science and Technology, Khartoum, Sudan 4 teaching center in Khartoum for the second opinion and for further University of Medical Science and Technology, Khartoum, Sudan; Weill management. The indication for referral was suspected abnormal Medical College, Doha, Qatar; Qatar University-Medical School, Doha, fetus at 29 weeks. We did not have the full record of early pregnancy. Qatar; Feto-Maternal Center, Doha, Qatar At the Ian Donald teaching center, the ultrasound examination Corresponding Author: Badreldeen Ahmed, University of Medical revealed the following: the estimated fetal weight was found to be Science and Technology, Khartoum, Sudan; Weill Cornell Medical below the 10th centile. There was a marked polyhydramnios, and the College; Feto-Maternal Centre, Doha, Qatar, Phone: +974 55845583, e-mail: [email protected] deepest vertical pool measured 12 cm. The anterior abdominal was absent with protrusion of stomach, small bowel, and the liver (Fig. 1). How to cite this article: Mohmmed SDE, Elrayah N, et al. Pentalogy of Cantrell. Donald School J Ultrasound Obstet Gynecol 2019;13(2):83–84. Source of support: Nil Conflict of interest: None The thoracic wall was open with the fetal heart completely outside the chest. The diaphragm could not be visualized. -
Differential Diagnosis of Complex Conditions in Paleopathology: a Mutational Spectrum Approach by Elizabeth Lukashal a Thesis
Differential Diagnosis of Complex Conditions in Paleopathology: A Mutational Spectrum Approach by Elizabeth Lukashal A thesis presented to the University of Waterloo in fulfillment of the thesis requirement for the degree of Master of Arts in Public Issues Anthropology Waterloo, Ontario, Canada, 2021 © Elizabeth Lukashal 2021 Author’s Declaration I hereby declare that I am the sole author of this thesis. This is a true copy of the thesis, including any required final revisions, as accepted by my examiners. I understand that my thesis may be made electronically available to the public. ii Abstract The expression of mutations causing complex conditions varies considerably on a scale of mild to severe referred to as a mutational spectrum. Capturing a complete picture of this scale in the archaeological record through the study of human remains is limited due to a number of factors complicating the diagnosis of complex conditions. An array of potential etiologies for particular conditions, and crossover of various symptoms add an extra layer of complexity preventing paleopathologists from confidently attempting a differential diagnosis. This study attempts to address these challenges in a number of ways: 1) by providing an overview of congenital and developmental anomalies important in the identification of mild expressions related to mutations causing complex conditions; 2) by outlining diagnostic features of select anomalies used as screening tools for complex conditions in the medical field ; 3) by assessing how mild/carrier expressions of mutations and conditions with minimal skeletal impact are accounted for and used within paleopathology; and 4) by considering the potential of these mild expressions in illuminating additional diagnostic and environmental information regarding past populations. -
Prenatal Diagnosis of Cantrell Pentalogy in First Trimester Screening: Case Report and Review of Literature
Case Report 145 Prenatal diagnosis of Cantrell pentalogy in first trimester screening: case report and review of literature Birinci trimester anöploidi taramasında Cantrell pentalojisinin erken tanısı: olgu sunumu ve literatür taraması Mete Ahmet Ergenoğlu, A. Özgür Yeniel, Nuri Peker, Mert Kazandı, Fuat Akercan, Sermet Sağol Department of Gynecology and Obstetrics, Faculty of Medicine, Ege University, İzmir, Turkey Abstract Özet Pentalogy of Cantrell is a heterogeneous and rare thoraco-abdomi- Cantrell Pentalojisi tahmini prevalansı 1/65.000 ile 1/200.000 doğum- nal wall closure defect with the estimated prevalence of 1/65.000 to da bir izlenen heterojen ve nadir bir torako-abdominal duvara ait 1/200.000 births. Supraumbilical midline wall defect (generally om- kapanma defektidir. Supraumblikal orta hat defekti (genellikle omfa- phalocele), deficiency of the anterior diaphragm and diaphragmatic losel), anterior diyafram ve diyafragmatik periton defekti, sternumun peritoneum, defect of the lower sternum and several intracardiac de- alt kısmına ait defektler ile kalbe ait anomaliler Cantrell Pentalojisini fects are the components of Cantrell pentalogy. Etiology is unknown oluşturan bileşenlerdir. Etyolojisi bilinmemekle beraber erken gebelik but a defect on the lateral mesoderm during the early stage of preg- haftalarında lateral mezoderme ait defektlerden kaynaklandığı hipo- nancy is the most accepted hypothesis. Nowadays both 2- dimension- tezi en geçerli olanıdır. Günümüzde tanıda hem iki hem de üç boyut- al (2D) and 3-dimensional (3D) sonography are commonly used in lu sonografi kullanılmaktadır. Olgumuz birinci trimester taramasında diagnosis. In our case, a fetus with 11 weeks of gestation was reported Cantrell Pentalojisi tanısı alan 11. gebelik haftasındaki fetüs idi. Ek ola- as Cantrell pentalogy during first trimester screening. -
Uterine Structural Anomalies and Arthrogryposisdeath of an Urban Legend
RESEARCH ARTICLE Uterine Structural Anomalies and Arthrogryposis—Death of an Urban Legend Judith G. Hall* Departments of Medical Genetics and Pediatrics, University of British Columbia and BC Children’s Hospital, Vancouver, British Columbia, Canada Manuscript Received: 18 April 2012; Manuscript Accepted: 23 August 2012 In a review of 2,300 cases of arthrogryposis collected over the last 35 years, 33 cases of maternal uterine structural anomalies were How to Cite this Article: identified (1.3%). These cases of arthrogryposis represent a very Hall JG. 2013. Uterine structural anomalies heterogeneous group of types of arthrogryposis. Over half of and arthrogryposis—Death of an urban individuals affected with arthrogryposis demonstrated asymme- legend. try and some responded to removal of constraint, 29 of the 33 Am J Med Genet Part A 161A:82–88. cases of arthrogryposis whose mother had a uterine structural anomaly could be identified as having a specific recognizable type of arthrogryposis. Only two cases (0.08%) had primarily prox- imal contractures that returned to almost normal function within the uterus, intrauterine vascular compromise, maternal within 1 year. Craniofacial asymmetry was the most striking illness and exposure to specific drugs or medications. Once fetal finding in these two cases. A quarter of cases had ruptured akinesia occurs, contractures at involvedjoints begin to develop, the membranes between 32 and 36 weeks and either oligohydram- longer the decreased fetal movement, the more severe the limitation nios or prematurity. The pregnancy histories of the mothers with of joint movement and the more likely that pterygia or constraining uterine structural anomalies were typical in having infertility, connective tissue will develop around the joint [Hall, 2012]. -
Pathogenesis of Horrifying Rare Genetic
The Pharma Innovation Journal 2017; 6(5): 85-89 ISSN (E): 2277- 7695 ISSN (P): 2349-8242 NAAS Rating 2017: 5.03 Pathogenesis of horrifying rare genetic disorders in TPI 2017; 6(5): 85-89 © 2017 TPI humans – A review www.thepharmajournal.com Received: 16-03-2017 Accepted: 17-04-2017 Gummalla Pitchaiah and E Pushpalatha Gummalla Pitchaiah Associate Professor Abstract Department of Pharmacology The identification of novel mutations causing genetic disease has seen more progress in the last few years Bharat Institute of Technology, than in the previous twenty. This increased body of research has resulted in a wealth of information Mangalpally (V), regarding the pathogenesis of rare genetic diseases. In this review, we illustrate the underlying Ibrahimpatnam (M), Ranga pathogenesis of few horrifying rare genetic diseases like Ectrodactyly, Proteus syndrome, Polymelia, Reddy (Dt), Telangana, India Neurofibromatoses, Diprosopus, Anencephaly, Cutaneous horn, Harlequin ichthyosis and Cyclopia in humans. E Pushpalatha Bharat Institute of Technology, Mangalpally (V), Keywords: Pathogenesis, rare disease, genetic Ibrahimpatnam (M), Ranga Reddy (Dt), Telangana, India 1. Introduction Diseases that affect less than 1/2000 individuals are referred to as rare; those with a prevalence lower than 1/50000 are referred to as ultra-rare. Rare genetic diseases are one of the most scientifically complex health challenges of our time. There are currently 7,000 known rare [1-2] diseases, of which 80% are genetic origin and half of which affect children . Rare diseases are characterized by diversity of symptoms that vary not only disease to disease but also from patient to patient affected by same disease. Rare diseases caused by altered functions of single genes can be chronically debilitating and life-limiting. -
Congenital Anomaly Surveillance 2015-2016
Final CONGENITAL ANOMALY SURVEILLANCE 2015-2016 Dr. James Robins Review of data relating to Congenital Anomalies detected in NHS Greater Glasgow &Clyde between 1st April 2015 and 31st March 2016. Source data provided by Hilary Jordan of Information Services. TABLE OF CONTENTS Contents Congenital Anomaly Surveillance _______________________________________________________________________ 1 Links to previous reports ________________________________________________________________________________ 4 Core Data _________________________________________________________________________________________________ 5 Point of diagnosis _______________________________________________________________________________________ 17 Pregnancy Outcome ____________________________________________________________________________________ 23 Endocrine & Metabolic Disorders _____________________________________________________________________ 28 Cranial & Spinal Abnormalities ________________________________________________________________________ 31 Cardiac & Circulatory Abnormalities __________________________________________________________________ 37 Malformations of the Respiratory System ____________________________________________________________ 45 Abnormalities of Ear, Eye, Face & Neck ________________________________________________________________ 47 Gastrointestinal Abnormalities ________________________________________________________________________ 52 Genitourinary System __________________________________________________________________________________ -
Congenital Anomalies Surveillance 2013-2014
NHS Greater Glasgow & Clyde CONGENITAL ANOMALIES SURVEILLANCE 2013-2014 REVIEW OF DATA RELATING TO CONGENITAL ANOMALIES DETECTED IN NHS GG&C BETWEEN 1 ST APRIL 2013 AND 31ST MARCH 2014 Dr. James Robins Source data provided by Hilary Jordan of Information Services Final 18th October 2014 Congenital Anomalies Report 2013-2014 Table of Contents Definitions ............................................................................................................................................... 5 Links to Previous Reports ........................................................................................................................ 6 GG&C Congenital Anomaly Report for 2012-2013 ............................................................................. 6 GG&C Congenital Anomaly Report for 2011-2012 ............................................................................. 6 1. Core Data ............................................................................................................................................ 7 1.1. Case based review ........................................................................................................................ 7 1.2. Abnormality based review ......................................................................................................... 10 1.3. Maternal Age ............................................................................................................................. 11 1.4. Gender ...................................................................................................................................... -
Nuove Politiche Per L'innovazione Nel Settore Delle Scienze Della Vita
Laura Magazzini Fabio Pammolli Massimo Riccaboni WP CERM 03-2009 NUOVE POLITICHE PER L'INNOVAZIONE NEL SETTORE DELLE SCIENZE DELLA VITA ISBN 978-88-3289-038-9 INDICE EXECUTIVE SUMMARY .................................................................................. 2 1. Risorse e innovazione: fallimenti di mercato e logiche di intervento pubblico........... 2 2. Da raro a generale: nuovi modelli di sostegno mission-oriented alla ricerca e sviluppo nelle scienze della vita............................................................................... 31 2.1. Incentivi pubblici per la ricerca sulle malattie rare: il panorama internazionale.....37 Stati Uniti...........................................................................................................................................................................................37 Giappone.............................................................................................................................................................................................44 Australia..............................................................................................................................................................................................46 Unione Europea.............................................................................................................................................................................46 2.2. Incentivi pubblici per la ricerca sulle malattie rare: il panorama europeo.....................58 Francia ..................................................................................................................................................................................................58